Member Exclusive NEWS ROUND-UP

Cell therapy weekly: job losses at Lonza and positive results in stage IV pancreas cancer

This week: autologous therapies shown to safe and tolerated in pancreatic cancer and type 1 diabetes trials, and new biopharma will develop candidate from MD Anderson Cancer Center.

Thumb rme journal large
Mar 08, 2018

Please sign in or register for FREE

No comments yet.